The Authors report on a case of facial paresis following the recurrency of labial Herpes simplex in a 59 year old woman treated with a sequential periocular BoNTA injection and blepharoplasty. A mild palsy occurred on the whole right hemiface 12 days after upper blepharoplasty, 22 days after the BoNTA injection (40 U) in the periorbital area and in the glabella. The patient was treated with Acyclovir for 5 days and with oral B complex vitamins for 12 weeks. The symptoms slowly disappeared after 4 months. Facial paresis might have been triggered by an invasive treatment-related inflammatory reaction. Nevertheless, the Herpes virus might have promoted the anterograde diffusion of the toxin, previously migrated from the site of injection to the facial nucleus through a retrograde pathway. The Authors suggest Acyclovir prophylaxis in patients affected by recent or recurrent forms of Herpes simplex infections when planning BoNTA injections in the face.

Facial paresis: A worrying event related to labial herpes simplex and periocular botulinum toxin a injection

Faga A.
;
Scevola S.;Toffola E. D.;
2023-01-01

Abstract

The Authors report on a case of facial paresis following the recurrency of labial Herpes simplex in a 59 year old woman treated with a sequential periocular BoNTA injection and blepharoplasty. A mild palsy occurred on the whole right hemiface 12 days after upper blepharoplasty, 22 days after the BoNTA injection (40 U) in the periorbital area and in the glabella. The patient was treated with Acyclovir for 5 days and with oral B complex vitamins for 12 weeks. The symptoms slowly disappeared after 4 months. Facial paresis might have been triggered by an invasive treatment-related inflammatory reaction. Nevertheless, the Herpes virus might have promoted the anterograde diffusion of the toxin, previously migrated from the site of injection to the facial nucleus through a retrograde pathway. The Authors suggest Acyclovir prophylaxis in patients affected by recent or recurrent forms of Herpes simplex infections when planning BoNTA injections in the face.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1496055
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact